Cited by 416Dementia and Cognitive Impairment ResearchHealth disparities and outcomesAlzheimer's disease research and treatments

Diversity and Disparity in Dementia: The Impact of Ethnoracial Differences in Alzheimer Disease

Open access
Chin, Alexander L., Negash, Selamawit, Hamilton, Roy·2011·Alzheimer Disease & Associated Disorders

Abstract

Debate exists regarding differences in the prevalence of Alzheimer disease (AD) in African Americans and Hispanics in the United States, with some evidence suggesting that the prevalence of AD may be considerably higher in these groups than in non-Hispanic whites. Despite this possible disparity, patients of minority ethnoracial groups often receive delayed diagnosis or inadequate treatment for dementia. This review investigates these disparities by conceptualizing the dementia disease process as a product of both biological and cultural factors. Ethnoracial differences in biological risk factors, such as genetics and cardiovascular disease, may help to explain disparities in the incidence and prevalence of AD, whereas race-specific cultural factors may impact diagnosis and treatment. Cultural factors include differences in perceptions about what is normal aging and what is not, lack of adequate access to medical care, and issues of trust between minority groups and the medical establishment. The diagnosis of AD in diverse populations may also be complicated by racial biases inherent in cognitive screening tools widely used by clinicians, but controlling for literacy level or using savings scores in psychometric analyses has the potential to mitigate these biases. We also suggest that emerging biomarker-based diagnostic tools may be useful in further characterizing diverse populations with AD. Recognizing the gap in communication that exists between minority communities and the medical research community, we propose that education and outreach are a critical next step in the effort to understand AD as it relates to diverse populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/wad.0b013e318211c6c9

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Race does not have a genetic basis, and genetic factors do not account for the large differences in prevalence and incidence among racial groups.

    “Race does not have a genetic basis, and genetic factors do not account for the large differences in prevalence and incidence among racial groups.”

    From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [306]

    In “Biological Basis of AD: Risk Factors in Diverse Populations” (page unavailable), the review says factors other than genetics may account for a large proportion of increased AD risk in non-white populations. But “Epidemiologic Differences and AD” describes the biological basis of race as poorly understood, not nonexistent, and the review does not rule out genetic contributions to differences in prevalence and incidence. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Race is a social construct with little to no genetic or biological basis.

    “Race is a social construct with little to no genetic or biological basis.”

    From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [332]

    The Epidemiologic Differences and AD section describes substantial diversity within ethnoracial groups and says race may serve as a surrogate for other dementia risk factors, including educational attainment. It does not state that race is a social construct with little to no genetic or biological basis; instead, it says the biological basis of race is poorly understood. The Introduction also discusses possible ethnoracial differences in genetic risk factors for Alzheimer’s disease. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Genetic factors do not account for the large differences in prevalence and incidence among racial groups.

    “Instead, race is an idea created and used throughout history by groups in power to justify their control and dominance over other groups, and genetic factors do not account for the large differences in prevalence and incidence among racial groups.”

    From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [332]

    The Biological Basis of AD section says genetic risk may be similar across groups and that factors other than genetics may account for a large proportion of increased AD risk. But the Introduction says genetic differences may help explain some differences in AD incidence and prevalence, so the categorical exclusion of genetic factors overstates the paper. Page numbers are not available in the supplied passages. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [49]Kawas CH Katzman R Epidemiology of dementia and Alzheimer’s disease Terry RD Katzman R Bick KL Alzheimer’s Disease 2 Philadelphia Lippincott Williams & Wilkins 1999 95 116
  2. [65]Manly JJ Jacobs D Mayeux R Alzheimer’s disease among different ethnic and racial groups Terry RD Katzman R Bick KL Alzheimer’s Disease 2 Philadelphia Lippincott Williams & Wilkins 1999 117 31
  3. [70]Byrd WM Clayton LA An American health dilemma: a medical history of African Americans and the problem of race 1 and 2 New York, New York Routledge 2000 2002 12510681

Cited by

Sorted by citations

Authors
Chin, A. L., Negash, S., & Hamilton, R.
Affiliations
University of Pennsylvania (US)
Corresponding author
Chin, Alexander L.
Venue
Alzheimer Disease & Associated Disorders
Published
2011-07
Volume
25
Issue
3
Pages
187-195
ISSN
0893-0341 (ISSN-L)
OpenAlex
W2000808937
Cited by
416
References
88
Citations by year
2026: 23 · 2025: 52 · 2024: 44 · 2023: 50 · 2022: 42 · 2021: 51 · 2020: 38 · 2019: 17 · 2018: 24 · 2017: 13 · 2016: 18 · 2015: 12 · 2014: 12 · 2013: 12 · 2012: 7
FWCI
7.00
Type
journal article
Language
en
Open access
Locations
  • Alzheimer Disease & Associated Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Center for Research Resources (KL2RR024151, K12RR24151)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Health › Health disparities and outcomes
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, dementia, racial disparities, African Americans, Hispanic Americans, minority health, cultural factors, biological risk factors, cardiovascular disease, genetic risk, health care access, literacy, biomarker-based diagnosis
MeSH terms
Alzheimer Disease, Black or African American, Hispanic or Latino, Humans, United States, Prevalence, White People, Health Status Disparities, Healthcare Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review